Chandrasekhar Bal
Papers
2
Total Citations
46
H-Index
2
About
Chandrasekhar Bal is a pioneering researcher whose work bridges the cutting-edge fields of epilepsy surgery and nuclear medicine. His primary research areas include minimally invasive neurosurgical techniques for drug-resistant epilepsy and the innovative production of radiopharmaceuticals for PET imaging. Bal’s most significant contribution is his development and comparative evaluation of endoscope-assisted hemispherotomy, a procedure that leverages robotic guidance and a hybrid technique to treat severe hemispheric epilepsy. His landmark 2018 study, which has garnered 43 citations, demonstrated that this minimally invasive approach offers comparable efficacy to traditional open hemispherotomy while potentially reducing complications, marking a paradigm shift in pediatric epilepsy surgery. In the realm of nuclear medicine, Bal devised a novel, cost-effective method to simultaneously produce both the bone PET agent ¹⁸F-fluoride and the widely used ¹⁸F-FDG in a single cyclotron run, minimizing radiation exposure. This achievement, detailed in his 2014 paper, showcases his ingenuity in optimizing clinical workflows. Through these dual contributions, Bal has significantly advanced both surgical outcomes for epilepsy patients and the efficiency of diagnostic imaging, establishing himself as a versatile innovator in translational medical research.
Research Focus
Key Achievements
Top Papers
- 1
- 2